REGN vs WING · P/E 14, rev $14.34B vs P/E 39, rev $625.8M
Regeneron Pharmaceuticals Inc (REGN) versus Wingstop Inc (WING) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Wingstop Inc (WING) is a restaurants company listed on NASDAQ.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported WING revenue for 2024-12-28 was $625.8M. Net income was $108.7M. Revenue was up 36.0% from 2023-12-30 to 2024-12-28. WING currently screens at market cap $4.29B and trailing P/E 38.9.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. WING currently screens at market cap $4.29B and trailing P/E 38.9.
Not investment advice. Open the REGN and WING stock pages for the full models.
Not investment advice.